$15.32 Million in Sales Expected for Global Medical REIT Inc (GMRE) This Quarter

Analysts expect that Global Medical REIT Inc (NYSE:GMRE) will report $15.32 million in sales for the current quarter, according to Zacks Investment Research. Five analysts have issued estimates for Global Medical REIT’s earnings. The lowest sales estimate is $15.02 million and the highest is $15.80 million. Global Medical REIT posted sales of $11.56 million during the same quarter last year, which would indicate a positive year over year growth rate of 32.5%. The firm is scheduled to issue its next earnings results after the market closes on Wednesday, May 8th.

On average, analysts expect that Global Medical REIT will report full-year sales of $67.88 million for the current fiscal year, with estimates ranging from $60.65 million to $73.07 million. For the next fiscal year, analysts expect that the firm will post sales of $81.52 million, with estimates ranging from $62.03 million to $95.74 million. Zacks’ sales averages are an average based on a survey of sell-side analysts that that provide coverage for Global Medical REIT.

Global Medical REIT (NYSE:GMRE) last posted its quarterly earnings data on Thursday, March 7th. The company reported $0.31 EPS for the quarter, topping the Zacks’ consensus estimate of $0.21 by $0.10. Global Medical REIT had a return on equity of 6.29% and a net margin of 22.62%. The firm had revenue of $14.38 million for the quarter, compared to analyst estimates of $14.46 million.

Several equities research analysts recently weighed in on the company. B. Riley set a $11.00 price objective on Global Medical REIT and gave the company a “buy” rating in a report on Friday, March 8th. Boenning Scattergood reiterated a “buy” rating on shares of Global Medical REIT in a report on Thursday, March 7th. Zacks Investment Research upgraded shares of Global Medical REIT from a “hold” rating to a “buy” rating and set a $10.00 price target on the stock in a report on Tuesday, January 8th. Finally, Stifel Nicolaus began coverage on shares of Global Medical REIT in a research report on Monday, April 15th. They issued a “buy” rating and a $11.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Global Medical REIT presently has an average rating of “Buy” and a consensus target price of $10.67.

Global Medical REIT stock traded down $0.11 during mid-day trading on Friday, reaching $10.07. 273,957 shares of the company were exchanged, compared to its average volume of 323,427. Global Medical REIT has a 12 month low of $8.08 and a 12 month high of $11.02. The company has a debt-to-equity ratio of 1.25, a current ratio of 0.11 and a quick ratio of 0.11. The firm has a market cap of $345.77 million, a PE ratio of 12.91, a price-to-earnings-growth ratio of 1.39 and a beta of 0.61.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, April 10th. Stockholders of record on Tuesday, March 26th were issued a $0.20 dividend. The ex-dividend date was Monday, March 25th. This represents a $0.80 annualized dividend and a dividend yield of 7.94%. Global Medical REIT’s dividend payout ratio is currently 102.56%.

In other news, Director Roscoe M. Moore, Jr. sold 5,945 shares of the business’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $9.75, for a total value of $57,963.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 11.70% of the company’s stock.

Large investors have recently bought and sold shares of the company. Raymond James Financial Services Advisors Inc. lifted its holdings in Global Medical REIT by 59.0% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 69,450 shares of the company’s stock valued at $682,000 after purchasing an additional 25,770 shares in the last quarter. American International Group Inc. lifted its holdings in Global Medical REIT by 15.5% during the first quarter. American International Group Inc. now owns 14,404 shares of the company’s stock valued at $141,000 after purchasing an additional 1,934 shares in the last quarter. Schnieders Capital Management LLC lifted its holdings in Global Medical REIT by 31.0% during the first quarter. Schnieders Capital Management LLC now owns 17,100 shares of the company’s stock valued at $168,000 after purchasing an additional 4,050 shares in the last quarter. Stevens Capital Management LP purchased a new position in Global Medical REIT during the first quarter valued at $139,000. Finally, Wedge Capital Management L L P NC lifted its holdings in Global Medical REIT by 1.0% during the first quarter. Wedge Capital Management L L P NC now owns 124,181 shares of the company’s stock valued at $1,219,000 after purchasing an additional 1,271 shares in the last quarter. Institutional investors and hedge funds own 35.28% of the company’s stock.

Global Medical REIT Company Profile

Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Read More: Limitations of the P/E Growth ratio

Get a free copy of the Zacks research report on Global Medical REIT (GMRE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.